According to rating firm ICRA, BE reported revenues of Rs 2,556.8 crore in FY22, largely driven by the government's Rs 1,500-crore contract order for supplying Corbevax vaccine against Covid.
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/JqQ3rPw
https://ift.tt/QXUAG9o
from Latest Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/JqQ3rPw
https://ift.tt/QXUAG9o
إرسال تعليق